NAMPT and laryngotracheoesophageal cleft: Logistic regression analysis, adjusted for gender, age, ethnicity, and drinking status, showed that no single genotype or allele of visfatin -3187G>A loci was associated with an altered risk for CHB, HBV-LC, or HBV-HCC (all P > 0.05; see Table 2).